SEC FORM 4
$96,170.40
Skye Bioscience, Inc. (SKYE)
Sale of 253,080 shares at $0.38 per share.
Reporting Persons 5AM Partners VII, LLC · 5AM Ventures VII, L.P. · 5AM Partners II, LLC · 5AM Ventures II LP · 5AM CO-INVESTORS II LP · DIEKMAN JOHN D · PARMAR KUSH · ROCKLAGE SCOTT M · Transaction Code S
Traded Aug 18, 2026 · Disclosed Aug 20, 2026
Source: SEC Form 4 · 0001231919-26-000959 · filed 2026-08-20 · View filing →